NFYB
NFYB or Nuclear Transcription Factor Y Subunit Beta is a protein that in humans is encoded by the NFYB gene. This protein is a part of the Nuclear Transcription Factor Y (NF-Y) complex, which plays a critical role in the transcription of genes involved in cell cycle regulation, differentiation, and development. NFYB, along with NFYA and NFYC, forms the trimeric NF-Y complex, which binds to the CCAAT motif within the promoters of target genes, facilitating transcriptional activation or repression depending on the context.
Function[edit | edit source]
The NF-Y complex is unique in its binding specificity to the CCAAT box, a common promoter element found in about 30% of eukaryotic genes. NFYB, the beta subunit, is essential for the DNA-binding and transcriptional activity of the NF-Y complex. It interacts directly with NFYC, and this interaction is critical for the formation of the NF-Y trimeric complex. The NF-Y complex is involved in the regulation of a diverse set of genes, including those involved in cell cycle control, apoptosis, DNA repair, and lipid metabolism.
Structure[edit | edit source]
NFYB is characterized by a highly conserved domain necessary for the formation of the NF-Y complex. This domain facilitates the interaction with the NFYC subunit, and together, they provide a structural scaffold for the DNA-binding subunit, NFYA, to interact with the CCAAT box in the DNA. The NFYB subunit does not directly bind DNA but is essential for the structural integrity and function of the NF-Y complex.
Clinical Significance[edit | edit source]
Alterations in the expression or function of NFYB have been implicated in various human diseases, including cancer, cardiovascular diseases, and neurodegenerative diseases. Given its role in cell cycle regulation and apoptosis, NFYB is considered a potential target for therapeutic intervention in cancer and other diseases characterized by abnormal cell proliferation.
Research[edit | edit source]
Research on NFYB has focused on understanding its role in gene regulation and its potential as a therapeutic target. Studies have explored the mechanism by which NFYB and the NF-Y complex contribute to the regulation of specific genes and how alterations in NFYB expression affect cell function and disease progression.
NFYB Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD